
GE HealthCare Revenues Climb 6% Despite Tariff Squeezes
GE HealthCare Technologies Inc.Description
What this story covers
GE HealthCare's Q3 revenues rose 6% to $5.1B, driven by diagnostics and AI growth, though margins shrank from tariffs and costs. Strong liquidity at $4B cash supports acquisitions like Nihon Medi-Physics, amid China slowdowns and geopolitical risks. Strategy focuses on precision care innovation for resilience.
Story snapshot
CompanyGE HealthCare Technologies Inc.
TickerGEHC
VariantStandard detailed
Duration12:13
Filing type10-Q
PeriodQ3 2025
IndustryHealthcare & Pharmaceuticals
Accession0001932393-25-000053
Full Story Script
Content not available for this story.